Baseline characteristics

Study of BTK Inhibitor BGB-3111 in Chinese Subjects With Relapsed/Refractory Waldenström's Macroglobulinemia (WM) · Source last updated 2024-10-26

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      44

   units

   Participants

groups

1. description

   Zanubrutinib 160 mg orally twice daily with or without food until progressive disease or intolerable toxicity

   id

   BG000

   title

   Zanubrutinib

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            spread

            8.10

            value

            64.7

   dispersion Type

   STANDARD_DEVIATION

   param Type

   MEAN

   title

   Age, Continuous

   unit Of Measure

   Years

2. calculate Pct

   false

   classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            17

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            27

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Sex: Female, Male

   unit Of Measure

   Participants

3. calculate Pct

   false

   classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            44

      title

      Chinese

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Race/Ethnicity, Customized

   unit Of Measure

   Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice